Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1271.00
-4.05
(-0.32%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr Reddy's completes acquisition of GSK's penicillin facility in US
>>
Dr Reddy’s launches anti-allergy tablets in US
>>
Dr Reddy’s may launch 3 new drugs in the US and to issue bonus debentures worth Rs 520 crore
>>
Dr Reddy’s eyes $1 bn revenue in next 3 years
>>
US court clears way for launch of Allegra D24 by Dr Reddy’s
>>
Dr Reddy's signs pact with R-Pharm of Russia
>>
Dr Reddy’s buys GSK’s oral penicillin facility in US
>>
Dr Reddy's gets nod to launch Zafirlukast
>>
Dr Reddy's enters into licensing deals with Cipla, UK company
>>
Dr Reddy's to sell Quetiapine in NZ
<<
<
140
141
142
...143
>
>>